Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes

Educational services, namely, a patient assistance and support program for patients and their healthcare providers, namely, providing educational information in the field of education regarding the delivery and administration of medication, and payer coverage and reimbursement

Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes, prescription drugs for the treatment of iron-a...

Educational services, namely, a patient assistance and support program for patients and their healthcare providers, namely, providing educational information in the field of education regarding the delivery and administration of medication, and payer coverage and reimbursement